MedTrace Logo

Surrogating Physician-recorded SCORE2 Risk Calculator Inputs by Using Auxiliary Data

NCT06831890 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-02-18

No results posted yet for this study

Summary

The goal of the clinical trial is to assess whether the data collected from wearable devices can reduce the uncertainty in predicting the cardiovascular disease (CVD) risk in women aged 40-69 years in a situation where information about the blood pressure and blood lipids are unavailable.

Participants will:

* Complete a screening and baseline assessment, including blood sample collection and vital parameter measurement.
* Wear a wearable device for one week.
* Fill in a work and sleep journal.
* Complete a last visit assessment.

Conditions

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Petra Stute, Prof. · University Hospital of Bern, Department of Gynecological Endocrinology & Reproductive Medicine

Eligibility

Min Age
40 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-24
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06831890 on ClinicalTrials.gov